Literature DB >> 11385966

Hepatic fibrosis. Pathogenesis and principles of therapy.

E Albanis1, S L Friedman.   

Abstract

There has been great progress made in our understanding of the cellular mechanisms of hepatic fibrosis. The recognition that the hepatic stellate cell, (formerly know as lipocyte, Ito, or fat-storing cell), played a central role in the fibrotic response was key to our understanding. Stellate cells undergo a process known as activation, in response to any insult. Activation is a broad phenotypic response, characterized by distinct functional changes in proliferation, fibrogenesis, contractility, cytokine secretion, and matrix degradation. Insights gained into the molecular regulations of stellate cell activation may lead to new antifibrotic therapies, which may reduce morbidity and mortality in patients with chronic liver injury.

Entities:  

Mesh:

Year:  2001        PMID: 11385966     DOI: 10.1016/s1089-3261(05)70168-9

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  57 in total

1.  Withagulatin A inhibits hepatic stellate cell viability and procollagen I production through Akt and Smad signaling pathways.

Authors:  Qiong Liu; Jing Chen; Xu Wang; Liang Yu; Li-hong Hu; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2010-07-19       Impact factor: 6.150

2.  Identification and functional characterization of the hepatic stellate cell CD38 cell surface molecule.

Authors:  Sandra March; Mariona Graupera; María Rosa Sarrias; Francisco Lozano; Pilar Pizcueta; Jaume Bosch; Pablo Engel
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism.

Authors:  Songbai Lin; Neeraj K Saxena; Xiaokun Ding; Lance L Stein; Frank A Anania
Journal:  Mol Endocrinol       Date:  2006-08-24

4.  Effects of total glucosides of peony on immunological hepatic fibrosis in rats.

Authors:  Hua Wang; Wei Wei; Ni-Ping Wang; Cheng-Yi Wu; Shang-Xue Yan; Li Yue; Ling-Ling Zhang; Shu-Yun Xu
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

5.  Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index.

Authors:  Robert P Myers; Mercedes De Torres; Françoise Imbert-Bismut; Vlad Ratziu; Frédéric Charlotte; Thierry Poynard
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

6.  Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study.

Authors:  Yi-Min Mao; Min-De Zeng; Lun-Gen Lu; Mo-Bin Wan; Cheng-Zhong Li; Cheng-Wei Chen; Qing-Chuen Fu; Ji-Yao Wang; Wei-Min She; Xiong Cai; Jun Ye; Xia-Qiu Zhou; Hui Wang; Shan-Ming Wu; Mei-Fang Tang; Jin-Shui Zhu; Wei-Xiong Chen; Hui-Quan Zhang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

7.  Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation.

Authors:  Jing-Lin Xia; Chunsun Dai; George K Michalopoulos; Youhua Liu
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis.

Authors:  Ramon Bataller; Robert F Schwabe; Youkyung H Choi; Liu Yang; Yong Han Paik; Jeffrey Lindquist; Ting Qian; Robert Schoonhoven; Curt H Hagedorn; John J Lemasters; David A Brenner
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

9.  Effects of the tyrosine protein kinase inhibitor genistein on the proliferation, activation of cultured rat hepatic stellate cells.

Authors:  Xiao-Jing Liu; Li Yang; Yong-Qiu Mao; Qiong Wang; Ming-Hui Huang; Yi-Ping Wang; Hong-Bin Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

10.  Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody.

Authors:  Xiao-Jing Liu; Li Yang; Hong-Bin Wu; Ou Qiang; Ming-Hui Huang; Ying-Ping Wang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.